Tracks safety of Zyprexa Relprevv injections in people with schizophrenia
Observes safety monitoring for Zyprexa Relprevv injections in adults with schizophrenia.
Key facts
- Who runs it
- Eli Lilly and Company
- Where
- Blue Bell, United StatesSee the site
- Trial code
- Registry title
- Zyprexa® Relprevv™ Patient Care Program
- Status
- Enrolling by invitation
- People taking part
- 4,000 people, planned
- Started
- 3 Mar 2010
- Planned end
- Jun 2026
- Type of study
- Observational
- Record updated
- 28 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The program is for adults with schizophrenia who are receiving Zyprexa Relprevv. It aims to lower the risk of problems from post-injection delirium/sedation syndrome (PDSS).
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Earlier treatment
- People must be receiving Zyprexa Relprevv and be enrolled in the Zyprexa Relprevv Patient Care Program.
Main reasons for not taking part
- Anyone not receiving Zyprexa Relprevv cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Any patients receiving Zyprexa Relprevv enrolled in Zyprexa Relprevv Patient Care Program
Who cannot take part
- Any patient not receiving Zyprexa Relprevv
Where in United States
- United BioSource CorporationBlue Bell, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of the Zyprexa Relprevv Patient Care Program is to mitigate the risk of negative outcomes associated with Zyprexa Relprevv post-injection delirium/sedation syndrome (PDSS).
The group in the trial
- Patients
All patients who will be receiving Zyprexa Relprevv must be enrolled into the Zyprexa Relprevv Patient Care Program
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Zyprexa® Relprevv™ Patient Care Program
- Plain-language title
- Tracks safety of Zyprexa Relprevv injections in people with schizophreniaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 January 2026